Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950162-11-000022
Filing Date
2011-01-14
Accepted
2011-01-14 14:42:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 CLAUDIO CAVAZZA SCHEDULE 13D/A claudio13dano16_011411.htm SC 13D/A 380788
  Complete submission text file 0000950162-11-000022.txt   382604
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 11530012
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 ROME ITALY L6 00000
Business Address
CAVAZZA CLAUDIO (Filed by) CIK: 0001164803 (see all company filings)

Type: SC 13D/A